6242 logo

Li Kang Biomedical Co., Ltd. Stock Price

TPEX:6242 Community·NT$1.2b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

6242 Share Price Performance

NT$0
-43.00 (-100.00%)
NT$0
-43.00 (-100.00%)
Price NT$0

6242 Community Narratives

There are no narratives available yet.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet and fair value.

3 Risks
2 Rewards

Li Kang Biomedical Co., Ltd. Key Details

NT$581.5m

Revenue

NT$187.6m

Cost of Revenue

NT$393.9m

Gross Profit

NT$311.9m

Other Expenses

NT$82.0m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
2.58
67.73%
14.11%
14.3%
View Full Analysis

About 6242

Founded
1982
Employees
n/a
CEO
Yu-Xiu Zheng
WebsiteView website
www.likangbio.com

Li Kang Biomedical Co., Ltd. manufactures and sells supplement, cosmeceutical, and hygienic drink products. It also engages in the management and consulting of tourism factory business; and offers telemarketing services. The company was formerly known as BAFO Technologies Corporation and changed its name to Li Kang Biomedical Co., Ltd. in September 2014. Li Kang Biomedical Co., Ltd. was founded in 1982 and is based in Tainan City, Taiwan.

Recent 6242 News & Updates

Recent updates

No updates